Replimune REPL
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$24.89M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 26.53% to 25.96% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Emerald Advisers, LLC | Mutual Fund | 2026/Q3 | +3,644,844 | 3.8% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,444,862 | 2.3% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,444,862 | 2.3% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +499,549 | 3.6% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +171,895 | 0.9% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +167,000 | 0.2% |
| Erste Asset Management GmbH | Mutual Fund | 2026/Q3 | +165,000 | 2.4% |
| Montanova Capital, LLC | Hedge Fund | 2026/Q3 | +2,219,164 | 7.0% |
| Ridgeback Capital Management LLC | Mutual Fund | 2026/Q3 | +7,310,656 | 7.7% |
| Boxer Capital Management, LLC | Hedge Fund | 2026/Q3 | +2,808,000 | 4.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,719,296 | 9.5% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +2,500,000 | 2.6% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +2,295,024 | 2.7% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +2,221,121 | 4.6% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +1,894,400 | 2.5% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 8 Nov 2026 | Joseph Slattery | Independent Director | Open Market Disposition | -5,200 | $21.80 | 1,467 |
| 2 Nov 2026 | Paolo Pucci | Former Independent Director | Intent to Sell (Form 144) | -138,700 | $20.43 | – |
| 1 Nov 2026 | Kapil Dhingra | Independent Director | Derivative Exercise and Sale | -21,500 | $19.00 | 21,669 |
| 1 Nov 2026 | Kapil Dhingra | Independent Director | Derivative Exercise and Retained | +21,669 | $1.75 | 21,669 |
| 29 Oct 2026 | Veleka Peeples-Dyer | Former Independent Director | Intent to Sell (Form 144) | -10,000 | $16.72 | – |
| 27 Oct 2026 | Veleka Peeples-Dyer | Former Independent Director | Intent to Sell (Form 144) | -12,000 | $12.90 | – |
| 19 Aug 2026 | Philip Astley-Sparke | Executive Chairperson | Other Disposition | -50,000 | – | 1,276,889 |
| 16 Aug 2026 | Emily Hill | Chief Financial Officer | Open Market Disposition | -9,256 | $14.28 | 37,937 |
| 10 Aug 2026 | Baker Bros. Advisors LP | Open Market Derivative Acquisiti | +2,736,340 | $0.00 | 2,609,946 | |
| 9 Aug 2026 | Emily Hill | Chief Financial Officer | Open Market Disposition | -11,448 | $12.97 | 26,361 |
| 9 Aug 2026 | Sushil Patel | Chief Executive Officer | Open Market Disposition | -39,341 | $12.97 | 80,243 |
| 9 Aug 2026 | Andrew Schwendenman | Chief Accounting Officer & Treasurer | Open Market Disposition | -7,632 | $12.97 | 17,273 |
| 9 Aug 2026 | Konstantinos Xynos | Chief Medical Officer | Open Market Disposition | -11,447 | $12.97 | 50,258 |
| 31 May 2026 | Christopher Sarchi | Former Chief Commercial Officer | Automatic Disposition | -12,000 | $9.24 | 31,725 |
| 17 May 2026 | Philip Astley-Sparke | Executive Chairperson | Open Market Disposition | -17,657 | $5.08 | 1,326,889 |
| 17 May 2026 | Emily Hill | Chief Financial Officer | Open Market Disposition | -7,812 | $5.08 | 37,809 |
| 17 May 2026 | Sushil Patel | Chief Executive Officer | Open Market Disposition | -37,324 | $5.08 | 119,584 |
| 17 May 2026 | Christopher Sarchi | Former Chief Commercial Officer | Open Market Disposition | -8,626 | $5.08 | 43,724 |
| 17 May 2026 | Andrew Schwendenman | Chief Accounting Officer & Treasurer | Open Market Disposition | -7,894 | $5.08 | 24,905 |
| 17 May 2026 | Konstantinos Xynos | Chief Medical Officer | Open Market Disposition | -14,023 | $5.08 | 61,705 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 24,609,876 | 26.0% | 8.3 |
| 15 Oct 2026 | 23,165,699 | 24.6% | 12.7 |
| 30 Sep 2026 | 23,128,025 | 24.5% | 10.8 |
| 15 Sep 2026 | 22,754,597 | 24.2% | 11.1 |
| 31 Aug 2026 | 23,519,650 | 25.0% | 8.9 |
| 14 Aug 2026 | 24,866,611 | 26.5% | 4.0 |
No comments yet — be the first to weigh in on REPL.
Sign in to join the discussion.